Erschienen in:
01.02.2005 | Original Contributions
Relationship Between Surgeon Caseload and Sphincter Preservation in Patients With Rectal Cancer
verfasst von:
Harriett Purves, M.P.H., Ricardo Pietrobon, M.D., Ph.D., Sheleika Hervey, M.D., Ulrich Guller, M.D., M.H.S., William Miller, M.D., Ph.D., Kirk Ludwig, M.D.
Erschienen in:
Diseases of the Colon & Rectum
|
Ausgabe 2/2005
Einloggen, um Zugang zu erhalten
PURPOSE
The aim of this study was to determine by means of a national database whether higher surgeon caseload correlates with greater utilization of sphincter-sparing procedures than of abdominoperineal resections in treatment of patients with rectal cancer.
METHODS
Patients with a primary International Classification of Diseases-9 diagnosis code of rectal cancer who underwent a sphincter-sparing procedure or abdominoperineal resection were selected from the 1997 Nationwide Inpatient Sample, a database that represents 20 percent of all U.S. community hospital discharges. Multivariable logistic regression models were used on a 20 percent sample of this database to estimate the risk-adjusted relationship between surgeon caseload volume and the odds of receiving a sphincter-sparing procedure. All models were adjusted for age, gender, race, hospital region, and patient comorbidity.
RESULTS
The study population (n = 477) was 70.4 percent white and 57.9 percent male with an average age of 67.6 years. The mean Deyo comorbidity score was 7.0. Patients treated by surgeons in the highest-volume category (≥10 rectal cancer surgeries per year) compared with those treated by surgeons in the lowest-volume category (1–3 rectal cancer surgeries per year) were significantly more likely to undergo a sphincter-sparing procedure, after adjustment for other covariates (odds ratio = 5.05; 95 percent confidence interval, 2.5–10.22).
CONCLUSION
This analysis suggests that rectal cancer patients treated by high-volume surgeons are five times more likely to undergo sphincter-sparing procedures than those treated by low-volume surgeon. This has significant implications for those seeking a sphincter-preserving option for the treatment of their rectal cancer.